Disclosure Panels Details Page
Head and Neck Cancers Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Douglas Adkins MD | Adlai-Nortye astrazeneca BeiGene BioAtla Blueprint Medicines Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Calladitis Celgene Corporation CUE Biosciences Debio Eisai Inc. Eli Lilly and Company Epizyme Exelixis Inc. Genmab Gilead Sciences, Inc. Hookipa Pharma Inc Immunotep Isa Therapeutics Kura Oncology, Inc. Merck & Co., Inc. Natco Pfizer Inc. Roche Laboratories, Inc. Tizona Vaccinex |
boerhinger ingelheim Eisai Inc. Exelixis Inc. Genmab Immunitas Jazz Pharmaceuticals Inc. Kura Oncology, Inc. Merck & Co., Inc. Pfizer Inc. ppd SeaGen Vaccinex Xilio |
None | None | 03/06/2023 |
| Andrew Birkeland MD | None | None | None | None | 02/26/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| David Brizel MD | Biomimetix | Medical malpractice case | None | None | 03/30/2023 |
| Paul Busse PhD,MD | None | None | None | None | 02/21/2023 |
| Jimmy Caudell PhD,MD | Varian Medical Systems, Inc. | None | None | None | 02/24/2023 |
| Anthony Cmelak MD | None | None | None | None | 03/02/2023 |
| A. Dimitrios Colevas MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP atara Audro Biotech BeiGene bioN tech Bristol-Myers Squibb Company Cell Sight cellsight COTA Inc. cue biopharma cullinan Exelixis Inc. Gilead Sciences, Inc. incyte innate pharma iqvia Keyquest LOXO Oncology pds biotechnology corporation Pfizer Inc. PRA health sciences rakuten replimune tessa Threshold Pharmaceuticals viracta |
None | None | None | 03/24/2023 |
| Susan Darlow PhD | None | None | None | None | 01/04/2023 |
| Greg Durm MS,MD | Bristol-Myers Squibb Company Merck & Co., Inc. |
AstraZeneca Pharmaceuticals LP Curio Science Dava Oncology |
None | None | 03/03/2023 |
| Carole Fakhry MD,MPH | Merck & Co., Inc. | None | None | None | 03/21/2023 |
| Thomas Galloway MD | None | None | None | None | 02/01/2023 |
| Jessica Geiger MD | Alkermes Debio Genentech, Inc. Merck & Co., Inc. Outside academic institution Regeneron Pharmaceuticals, Inc. |
Astellas Pharma US, Inc. Exelixis Inc. Merck & Co., Inc. Regeneron Pharmaceuticals, Inc. |
None | None | 01/25/2023 |
| Maura Gillison PhD,MD | Agenus BioMimetix BioNTech AG Bristol-Myers Squibb Company Cullinan Genentech, Inc. Genocea Biosciences Gilead Sciences, Inc. Kura Oncology, Inc. |
Caladrius Biosciences Coherus BioSciences Exelixis Inc. GlaxoSmithKline iTeos Therapeutics LLX Solutions, LLC Merus N.V. |
None | None | 03/17/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Robert Haddad MD | AstraZeneca Pharmaceuticals LP Boehringer Ingelheim GmbH Bristol-Myers Squibb Company EMD Serono Genentech, Inc. GlaxoSmithKline Hookipa Pharma Inc ISA Kura Oncology, Inc. Merck & Co., Inc. Nanabiotix Pfizer Inc. |
ALX Oncology AstraZeneca Pharmaceuticals LP Bluedot Boehringer Ingelheim GmbH Eisai Inc. EMD Serono Exelixis Inc. G1 Therapeutics Galera Genmab Merck & Co., Inc. Merus Scholar Rock Vaccinex |
None | UpToDate | 05/22/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| Laura Hanisch PsyD | None | None | None | None | 12/13/2022 |
| Kyle Herrmann BSN,RN,OCN | None | None | None | None | 03/06/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Wesley Hicks, Jr. MD | Tactiva (start up Biotechnology Firm) | None | None | None | 03/16/2023 |
| Ying Hitchcock MD | None | None | None | None | 03/24/2023 |
| Anne Holbrook PharmD,BCOP | None | None | None | None | 02/02/2023 |
| Antonio Jimeno PhD,MD | Bristol-Myers Squibb Company Cantargia Debiopharma Genentech, Inc. Iovance Khar Merck & Co., Inc. Moderna sanofi-aventis U.S. SQZ |
Bluedot Bio | None | Champions Oncology, Inc.|SuviCa | 05/01/2023 |
| Debra Leizman MD | None | None | None | None | 01/18/2023 |
| Megan Lyons MS | None | None | None | None | 02/17/2023 |
| Ellie Maghami MD,FACS | None | None | None | None | 02/02/2023 |
| Lisa McKale | None | None | None | None | 01/30/2023 |
| Nicole McMillian MS | None | None | None | None | 05/23/2023 |
| Loren Mell MD | AstraZeneca Pharmaceuticals LP EMD Serono Merck & Co., Inc. |
Cel-Sci Pfizer Inc. |
None | None | 03/21/2023 |
| Bharat Mittal MD | None | None | None | None | 02/01/2023 |
| Sarah Montgomery | None | None | None | None | 03/22/2023 |
| David Pfister MD | Akeso AstraZeneca Pharmaceuticals LP Atara GlaxoSmithKline Hookipa MedImmune Inc. Meira Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
Meira Nycode |
None | None | 01/25/2023 |
| Harlan Pinto MD | None | None | None | None | 03/04/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| James Rocco MD,PhD | None | None | None | UPTODATE | 02/08/2023 |
| Cristina Rodriguez MD | Acerta Pharma AstraZeneca Pharmaceuticals LP Ayala Bayer HealthCare BeiGene Bristol-Myers Squibb Company DeNovo Genentech, Inc. Incyte Corporation Kura Oncology, Inc. Merck & Co., Inc. Pharmacyclics Pionyr Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. |
AbbVie, Inc. ADC AstraZeneca Pharmaceuticals LP BeiGene Coherus Biosciences Cue Biopharma Epizyme Genentech Incyte Corporation Karyopharm Therapeutics Kite Pharma Millennium Pharmaceuticals, Inc. NuMab Therapeutics AG Vaccitech |
None | None | 03/28/2023 |
| Panayiotis Savvides PhD,MD | Replimmune IGNYTE | None | None | None | 05/15/2023 |
| David Schwartz MD | None | None | None | None | 05/16/2023 |
| Jatin Shah PhD,MD | None | None | None | None | 04/30/2023 |
| David Sher MD,MPH | Varian Medical Systems, Inc. | None | None | None | 03/27/2023 |
| Sharon Spencer MD | None | None | None | None | 05/24/2023 |
| Maie St. John MD,PhD | None | None | None | None | 03/03/2023 |
| He Wang MD,PhD | None | None | None | None | 02/14/2023 |
| Gregory Weinstein MD | None | None | None | Olympus Corporation | 01/17/2023 |
| Francis Worden MD | Soligenix | Eisai Eli Lilly and Company Exelixis Inc. LOXO Merck & Co., Inc. Regeneron Pharmaceuticals, Inc. |
None | None | 02/28/2023 |
| Justine Yang Bruce MD | Astellas Pharma US, Inc. Cellectar Biosciences Incyte Corporation Kura Oncology, Inc. Merck & Co., Inc. Nektar Therapeutics Seattle Genetics, Inc. |
Kura Oncology, Inc. | None | None | 03/03/2023 |
| Sue Yom PhD,MD | Bristol-Myers Squibb Company EMD Serono Merck & Co., Inc. |
None | None | Springer|UpToDate | 05/14/2023 |
| Weining Zhen MD | None | None | None | None | 03/26/2023 |